These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis? Vezzani A Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535 [TBL] [Abstract][Full Text] [Related]
3. Finding a better drug for epilepsy: antiepileptogenesis targets. Kobow K; Auvin S; Jensen F; Löscher W; Mody I; Potschka H; Prince D; Sierra A; Simonato M; Pitkänen A; Nehlig A; Rho JM Epilepsia; 2012 Nov; 53(11):1868-76. PubMed ID: 23061663 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation. Terrone G; Salamone A; Vezzani A Curr Pharm Des; 2017; 23(37):5569-5576. PubMed ID: 28950818 [TBL] [Abstract][Full Text] [Related]
6. Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities. Singh T; Goel RK Neurochem Res; 2021 Jun; 46(6):1305-1321. PubMed ID: 33665775 [TBL] [Abstract][Full Text] [Related]
7. WONOEP XI: Workshop summary by the Scientific Organizing Committee. de Curtis M; Nehlig A; Noebels J; Sankar R; Vezzani A Epilepsia; 2012 Jul; 53(7):1275-6. PubMed ID: 22578186 [No Abstract] [Full Text] [Related]
8. Novel discoveries in understanding the complexities of epilepsy and major depression. Dhir A Expert Opin Ther Targets; 2010 Jan; 14(1):109-15. PubMed ID: 20001214 [TBL] [Abstract][Full Text] [Related]
9. Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy. Srivastava A; Dixit AB; Banerjee J; Tripathi M; Sarat Chandra P Clin Chim Acta; 2016 Jan; 452():1-9. PubMed ID: 26506013 [TBL] [Abstract][Full Text] [Related]
12. Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis. Singh N; Vijayanti S; Saha L Int J Neurosci; 2018 Oct; 128(10):987-994. PubMed ID: 29447051 [TBL] [Abstract][Full Text] [Related]
13. Inflammation in Epileptic Encephalopathies. Shandra O; Moshé SL; Galanopoulou AS Adv Protein Chem Struct Biol; 2017; 108():59-84. PubMed ID: 28427564 [TBL] [Abstract][Full Text] [Related]
14. The role of inflammation in the development of epilepsy. Rana A; Musto AE J Neuroinflammation; 2018 May; 15(1):144. PubMed ID: 29764485 [TBL] [Abstract][Full Text] [Related]
18. Inflammation and reactive oxygen species as disease modifiers in epilepsy. Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074 [TBL] [Abstract][Full Text] [Related]
19. Curcumin Reduces Neuronal Loss and Inhibits the NLRP3 Inflammasome Activation in an Epileptic Rat Model. He Q; Jiang L; Man S; Wu L; Hu Y; Chen W Curr Neurovasc Res; 2018; 15(3):186-192. PubMed ID: 30062967 [TBL] [Abstract][Full Text] [Related]
20. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. Drion CM; van Scheppingen J; Arena A; Geijtenbeek KW; Kooijman L; van Vliet EA; Aronica E; Gorter JA J Neuroinflammation; 2018 Jul; 15(1):212. PubMed ID: 30037344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]